Homviora Arzneimittel Dr. Hagedorn GmbH & Co. KG
Homviora Arzneimittel Dr. Hagedorn GmbH & Co. KG is a registered legal entity registered in Germany under HRA 63475 München, and its current status with Handelsregister (Commercial Register) is active. The company was incorporated on 1 March 1967 and lists its registered address as München, Germany. 2 shareholders are on record for Homviora Arzneimittel Dr. Hagedorn GmbH & Co. KG, including at least one natural person recorded as a direct holder; the filing carries no beneficial-ownership flag, so that holder is noted here as a recorded shareholder rather than a confirmed ultimate beneficial owner (UBO). This profile is sourced directly from Handelsregister (Commercial Register) and was last updated on 28 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
2
Two shareholders are currently on record for Homviora Arzneimittel Dr. Hagedorn GmbH & Co. KG, which has no share capital divided into shares.
The largest of these is Violetta Horn, holding 51% — a majority holding — followed by Felizian Kühbeck at 49%.
Every shareholder shown is an individual, recorded as a direct holder at this level; the record carries no UBO/PSC flag, so beneficial-owner status is not confirmed here.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Violetta Horn | 51% | Handelsregister (Commercial Register) | |
| Felizian Kühbeck | 49% | Handelsregister (Commercial Register) |
Officers
3
Three officers are currently on record for Homviora Arzneimittel Dr. Hagedorn GmbH & Co. KG, filed with Handelsregister (Commercial Register). Günther Dierking (appointed 2001-12-06), Felizian Kühbeck (appointed 2018-04-27) and Violetta Horn (appointed 2018-04-27) all serve as Limited Partner.
Management authority at Homviora Arzneimittel Dr. Hagedorn GmbH & Co. KG sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
Homviora Arzneimittel Dr. Hagedorn GmbH & Co. KG has no recorded parent company — it sits at the top of its own group structure, with 1 subsidiary recorded beneath it across 2 jurisdictions. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
Those 1 subsidiary spans Germany, Austria jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Homviora Arzneimittel Dr. Hagedorn GmbH & Co. KG
Germany
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns Homviora Arzneimittel Dr. Hagedorn GmbH & Co. KG?
Two shareholders are currently on record for Homviora Arzneimittel Dr. Hagedorn GmbH & Co. KG, which has no share capital divided into shares. The largest of these is Violetta Horn, holding 51% — a majority holding — followed by Felizian Kühbeck at 49%. Every shareholder shown is an individual, recorded as a direct holder at this level; the record carries no UBO/PSC flag, so beneficial-owner status is not confirmed here.
Who is Homviora Arzneimittel Dr. Hagedorn GmbH & Co. KG's UBO (Ultimate Beneficial Owner)?
At least one shareholder recorded for Homviora Arzneimittel Dr. Hagedorn GmbH & Co. KG is a natural person. The record carries no dedicated UBO/PSC flag, so that holder is stated here as a recorded shareholder rather than a confirmed Ultimate Beneficial Owner (UBO).
How many shareholders does Homviora Arzneimittel Dr. Hagedorn GmbH & Co. KG have on record?
2 shareholders are shown on record for Homviora Arzneimittel Dr. Hagedorn GmbH & Co. KG.
What is Homviora Arzneimittel Dr. Hagedorn GmbH & Co. KG's company registration number?
Homviora Arzneimittel Dr. Hagedorn GmbH & Co. KG's registration number is HRA 63475 München, filed with Handelsregister (Commercial Register) in Germany. Its current status on the register is active.
Is Homviora Arzneimittel Dr. Hagedorn GmbH & Co. KG still an active company?
Homviora Arzneimittel Dr. Hagedorn GmbH & Co. KG's status on Handelsregister (Commercial Register) is listed as active.
When was Homviora Arzneimittel Dr. Hagedorn GmbH & Co. KG incorporated?
Homviora Arzneimittel Dr. Hagedorn GmbH & Co. KG was incorporated on 1 March 1967, according to Handelsregister (Commercial Register).
What is Homviora Arzneimittel Dr. Hagedorn GmbH & Co. KG's registered address?
The registered address on file for Homviora Arzneimittel Dr. Hagedorn GmbH & Co. KG is München, Germany.
Who are the officers/directors of Homviora Arzneimittel Dr. Hagedorn GmbH & Co. KG?
Three officers are currently on record for Homviora Arzneimittel Dr. Hagedorn GmbH & Co. KG, filed with Handelsregister (Commercial Register). Günther Dierking (appointed 2001-12-06), Felizian Kühbeck (appointed 2018-04-27) and Violetta Horn (appointed 2018-04-27) all serve as Limited Partner. Management authority at Homviora Arzneimittel Dr. Hagedorn GmbH & Co. KG sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does Homviora Arzneimittel Dr. Hagedorn GmbH & Co. KG have a parent company or subsidiaries?
Homviora Arzneimittel Dr. Hagedorn GmbH & Co. KG has no recorded parent company — it sits at the top of its own group structure, with 1 subsidiary recorded beneath it across 2 jurisdictions. Those 1 subsidiary spans Germany, Austria jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Can Zavia monitor changes to Homviora Arzneimittel Dr. Hagedorn GmbH & Co. KG's ownership over time?
This profile reflects a point-in-time snapshot from Handelsregister (Commercial Register). Zavia's monitoring API can track changes to Homviora Arzneimittel Dr. Hagedorn GmbH & Co. KG's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Homviora Arzneimittel Dr. Hagedorn GmbH & Co. KG's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Germany, so records like Homviora Arzneimittel Dr. Hagedorn GmbH & Co. KG's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Handelsregister (Commercial Register) and was last synced on 28 October 2026.